Inflammation and stroke

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 1-3

  Ouyang, Yi Bing ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN TISSUE; CAUSE OF DEATH; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CYTOKINE RELEASE; DISABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NOTE; PRIORITY JOURNAL;

BRAIN ISCHEMIA; CYTOKINES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; MALE;

EID: 84880132992     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.031     Document Type: Note

References (40)

1. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
2. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 1999, 19:819-834.
3. Becker K., Kindrick D., Relton J., Harlan J., Winn R. Antibody to the alpha 4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 2001, 32:206-211.
4. Bradford J.R., Needham C.J., Bulpitt A.J., Westhead D.R. Insights into protein-protein interfaces using a Bayesian network prediction method. J. Mol. Biol. 2006, 362:365-386.
5. Burge J., Lane T., Link H., Qiu S., Clark V.P. Discrete dynamic Bayesian network analysis of fMRI data. Hum. Brain Mapp. 2009, 30:122-137.
6. Ceulemans A.G., Zgavc T., Kooijman R., Hachimi-Idrissi S., Sarre S., Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J. Neuroinflamm. 2010, 7:74.
7. Clausen B.H., Lambertsen K.L., Meldgaard M., Finsen B. A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 2005, 132:879-892.
8. Clausen B.H., Lambertsen K.L., Babcock A.A., Holm T.H., Dagnaes-Hansen F., Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflamm. 2008, 5:46.
9. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 2003, 62:127-136.
10. Denes A., Thornton P., Rothwell N.J., Allan S.M. Inflammation and brain injury: acute cerebral ischaemia peripheral and central inflammation. Brain Behav. Immun. 2010, 24:708-723.
11. Emsley H.C., Tyrrell P.J. Inflammation and infection in clinical stroke. J. Cereb. Blood Flow Metab. 2002, 22:1399-1419.
12. Ginsberg M.D. Neuroprotection for ischemic stroke: past present and future. Neuropharmacology 2008, 55:363-389.
13. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 2006, 83:461S-465S.
14. Hack C.E., Haber L.T., Maier A., Shulte P., Fowler B., Lotz W.G., Savage R.E. A Bayesian network model for biomarker-based dose response. Risk Anal. 2010, 30:1037-1051.
15. Hallenbeck J.M. Significance of the inflammatory response in brain ischemia. Acta Neurochir. Suppl. 1996, 66:27-31.
16. Han H.S., Yenari M.A. Cellular targets of brain inflammation in stroke. Curr. Opin. Investig. Drugs 2003, 4:522-529.
17. Hill J.K., Gunion-Rinker L., Kulhanek D., Lessov N., Kim S., Clark W.M., Dixon M.P., Nishi R., Stenzel-Poore M.P., Eckenstein F.P. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res. 1999, 820:45-54.
18. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 2009, 7:97.
19. Lambertsen K.L., Biber K., Finsen B. Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab. 2012, 32:1677-1698.
20. Lambertsen K.L., Meldgaard M., Ladeby R., Finsen B. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2005, 25:119-135.
21. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., Ford E., Furie K., Go A., Greenlund K., Haase N., Hailpern S., Ho M., Howard V., Kissela B., Kittner S., Lackland D., Lisabeth L., Marelli A., McDermott M., Meigs J., Mozaffarian D., Nichol G., O'Donnell C., Roger V., Rosamond W., Sacco R., Sorlie P., Stafford R., Steinberger J., Thom T., Wasserthiel-Smoller S., Wong N., Wylie-Rosett J., Hong Y. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
22. McCoy M.K., Tansey M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflamm. 2008, 5:45.
23. Morioka T., Kalehua A.N., Streit W.J. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J. Comp. Neurol. 1993, 327:123-132.
24. Pang L., Ye W., Che X.M., Roessler B.J., Betz A.L., Yang G.Y. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 2001, 32:544-552.
25. Planas A.M., Gorina R., Chamorro A. Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem. Soc. Trans. 2006, 34:1267-1270.
26. Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I., Iwaki T., Okada Y., Iida M., Cua D.J., Iwakura Y., Yoshimura A. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 2009, 15:946-950.
27. Simi A., Tsakiri N., Wang P., Rothwell N.J. Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans. 2007, 35:1122-1126.
28. Smith C.J., Emsley H.C., Gavin C.M., Georgiou R.F., Vail A., Barberan E.M., del Zoppo G.J., Hallenbeck J.M., Rothwell N.J., Hopkins S.J., Tyrrell P.J. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004, 4:2.
29. Spalletta G., Bossu P., Ciaramella A., Bria P., Caltagirone C., Robinson R.G. The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol. Psychiatry 2006, 11:984-991.
30. Spranger J., Kroke A., Mohlig M., Hoffmann K., Bergmann M.M., Ristow M., Boeing H., Pfeiffer A.F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52:812-817.
31. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14:3574-3589.
32. Tuttolomondo A., Di Raimondo D., Pecoraro R., Arnao V., Pinto A., Licata G. Inflammation in ischemic stroke subtypes. Curr. Pharm. Des. 2012, 18:4289-4310.
33. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
34. Whiteley W., Jackson C., Lewis S., Lowe G., Rumley A., Sandercock P., Wardlaw J., Dennis M., Sudlow C. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009, 6:e1000145.
35. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J. Am. Soc. Nephrol. 2004, 15:2792-2800.
36. Yan J., Greer J.M., Etherington K., Cadigan G.P., Cavanagh H., Henderson R.D., O'Sullivan J.D., Pandian J.D., Read S.J., McCombe P.A. Immune activation in the peripheral blood of patients with acute ischemic stroke. J. Neuroimmunol. 2009, 206:112-117.
37. Yang G.Y., Gong C., Qin Z., Liu X.H., Lorris Betz A. Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res. Mol. Brain Res. 1999, 69:135-143.
38. Yang G.Y., Gong C., Qin Z., Ye W., Mao Y., Bertz A.L. Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 1998, 9:2131-2134.
39. Yilmaz G., Granger D.N. Leukocyte recruitment and ischemic brain injury. Neuromol. Med. 2010, 12:193-204.
40. Zhao B., Mar J.C., Maruo S., Lee S., Gewurz B.E., Johannsen E., Holton K., Rubio R., Takada K., Quackenbush J., Kieff E. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:337-342.